Skip to main content
. 2015 Oct 29;5(4):e1093721. doi: 10.1080/2162402X.2015.1093721

Table 1.

Demographic data and clinic-biological characteristics of patients at diagnosis.

             
Demographic data and clinical characteristics MGUS (n = 86 ) SMM1 (n = 25 ) p < 2 MM (n = 53 ) p < 3  
Sex: Female/Male (% Females) 42/44 (48,8%) 17/8 (68.0%)   27/26 (50.9%)  
Age: years (Mean ± SEM ) 67.0 ± 1.4 65.6 ± 2.9   68.4 ± 1.7  
Risk and ISS stratification (n) 4 42 / 41 / 0 3 / 7 / 15   12 / 23 / 18  
Monoclonal component        
Monoclonal component, g/dL (Mean ± SEM ) 1.1 ± 0.1 1.6 ± 0.2 0.05 2.4 ± 0.3 0.001*
Bence Jones protein, no Yes/No (% Yes) 10/62 (13.9%) 11/12 (47.8%) 0.001 34/12 (73.9%) 0.001
Immunoparesis, no Yes/No (% Yes) 20/66 (23.3%) 21/4 (84%) 0.001 48/5 (90.6%) 0.001
Plasma cells (histology and immunophenotype)          
Histology-BMPC, % (Mean ± SEM ) 3.96 ± 0.3 16.5 ± 2.6 0.001 33.9 ± 2.9 0.001*
Ratio aberrant/total-BMPC (Mean ± SEM ) 73.1 ± 2.3 89.9 ± 4.1 0.001 96.0 ± 1.1 0.001
Fluorescent in situ hybridization (FISH)          
p53 deletion, no Yes/No (% Yes) 1/73 (1.3%) 2/20 (9.1%)   4/46 (8.0%)  
13q deletion, no Yes/No (%Yes) 3/70 (4.1%) 2/20 (9.1%)   12/37 (24.5%) 0.001
Break of IgH, no Yes/No (%Yes) 2/73 (2.7%) 4/18 (18.2%) 0.05 9/38 (19.1%) 0.01
Aneuploidy, no Yes/No (% Yes) 11/61 (15.3%) 6/14 (30.0%)   22/24 (57.8%) 0.001
Any FISH alteration, no Yes/No (%Yes) 15/61 (21.6%) 13/8 (61.9%) 0.001 34/14 (70.8%) 0.001

Chr, Chromosome; SEM indicates standard error of mean;

1

Following new criteria of the Myeloma Working Group,32 20 out of 25 SMM should be included in the MM group.

2

Significant difference between MGUS and SMM (Pearson's χ2, Fisher's exact or Mann–Whitney tests).

3

Significant difference between MGUS and MM (Pearson's χ2, Fisher's exact or Mann–Whitney tests).

4

Risk factors (0/1/2 score) in MGUS and SMM, and international scoring system (ISS, I/II/III score) in MM. 33,34

*

Differences lower than p < 0.05 between SMM and MM.